A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.
Ponticelli C, Yussim A, Cambi V, Legendre C, Rizzo G, Salvadori M, Kahn D, Kashi H, Salmela K, Fricke L, Heemann U, Garcia-Martinez J, Lechler R, Prestele H, Girault D; Simulect Phase IV Study Group.
Ponticelli C, et al.
Transplantation. 2001 Oct 15;72(7):1261-7. doi: 10.1097/00007890-200110150-00014.
Transplantation. 2001.
PMID: 11602853
Clinical Trial.